Advanced breast cancer, also known as metastatic breast cancer or secondary breast cancer, means cancer that has spread from the breast to other areas of the body.
There are two benign thyroid diseases these are: Hyperthyroidism (an overactive thyroid) and a Hypothyroidism (an underactive thyroid).
Bladder removal, or cystectomy, may be necessary to treat some bladder cancers. The London Clinic can treat bladder cancer with the use of robotics.
The cause of most bowel cancers is still unknown, but we do know that risk increases with age (95% of bowel cancer cases are found in people aged 50 or over*).
A primary brain tumour is a tumour that started growing in the tissues of the brain. There are nearly 100 different types of brain tumours. They are generally named after the type of cells they started growing from.
Women generally develop one of three types of breast cancer recurrence such as: local breast cancer recurrence, regional breast cancer recurrence and distant breast cancer recurrence.
Cancer of the cervix is a malignant tumour that forms in the tissues of the cervix (the organ connecting the uterus and vagina in women). The cervix is sometimes referred to as the neck of the womb.
Colon cancer is a malignant tumour that starts in the colon (the large bowel) or the rectum (sometimes called the back passage).
Early stage breast cancer means breast cancer that has not yet spread beyond the breast or the lymph nodes in the nearest armpit.
Eye melanoma, also called ocular melanoma, is a rare type of eye cancer that arises in melanocytes. These pigmented cells occur in several different tissues in the eye. An eye melanoma can develop from an obvious benign mole in the eye or from tissue that does not appear obviously pigmented.
Cancer can develop in any of the tissues or organs in the head and neck. Most commonly cancer starts to grow in the cells that form the lining of the mouth, nose, throat, ear or the surface of the tongue.
Lesions in the liver can be benign or malignant. Benign lesions are often an incidental finding and rarely cause any clinical concern. However some may require monitoring and rarely surgery is required to remove them.
Lung cancer is a malignant tumour that starts in the cells of the lung tissue. There are two main types of primary lung cancer, small cell lung cancer and nonsmall cell lung cancer. Mesothelioma is a much less common type of cancer that affects the covering of the lungs. It is more common in people who have been exposed to asbestos.
Lymphoedema describes an abnormal build-up of fluid that occurs when parts of the lymphatic system are missing or damaged. This leads to swelling in the arm or leg nearest to the damage, or in the main part of the body.
Lymphoma is a cancer of the lymphatic system, a system that’s primary function is in supporting the body’s immune functions. In lymphoma, cancer develops in one or more groups of lymph nodes. Lymphoma is defined in two groups: Hodgkin lymphoma and Non-Hodgkin lymphoma.
Around one in 10 men with breast cancer are found to have a mutation in the BRCA2 breast cancer gene. Men who have gynaecomastia commonly known as ‘man boobs’, or ‘moobs’ develop excess glandular tissue in their breast area and are more likely to develop breast cancer.
Neuroendocrine tumours (NETs) are abnormal masses of neuroendocrine cells. They can be benign or malignant and most commonly occur in the digestive system.
Prostate cancer is a malignant tumour that starts in the cells of the prostate. It generally affects men over 50, but can also affect younger men.
Secondary bone metastases may be isolated to one particular location or may be found in many bones throughout the body.
Skin cancer diagnosis is increasing despite media messages regarding sun protection and increased awareness amongst the public. The most serious types of skin cancer can be life threatening. For this reason, it is important to protect your skin from the sun and remain vigilant for new or changing growths. Fortunately, most types of skin cancer to do not threaten general health or decrease life expectancy, but will still require some treatment.
General enquiries: 020 7935 4444 Appointments: 020 7616 7693 Self-Pay: 020 3219 3315
Your call may be recorded for training and monitoring purposes.